title: Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis.
abstract: OBJECTIVE
  Liver regeneration after surgical resection is still a serious concern. The present study is designed to understand the relations between liver injury/regeneration and cytokines after hepatectomy with viral hepatitis.
  
  
  METHODS
  Twenty-one consecutive patients undergoing liver resection were studied, which included two patients with biliary tract cancer, three patients with hepatic metastases from colorectal cancer, and sixteen patients with primary liver tumor. They were also divided into two groups according to the existence of chronic viral hepatitis: 10 patients with viral hepatitis and 11 patients without viral hepatitis.
  
  
  RESULTS
  Viral hepatitis reduced pre-operative liver function (ICG-R15 and platelet count) with raised levels of sFas. Interestingly, this also reduced postoperative surge of IL-6, but not HGF, though they were equally at basal levels pre-operatively. Recovery of liver size, calculated with resected liver mass and volumetry with CT scan, was deteriorated in liver with viral hepatitis, but any difference of postoperative liver damage was observed between two groups.
  
  
  CONCLUSIONS
  Viral infection, somehow, increased sFas level pre-operatively, but does not influence the post-operative liver injury. Deficient response of IL-6, but not HGF, may be a major cause for poor liver regeneration after hepatectomy in patients with viral hepatitis independent from liver injury.
authors.affiliation: Department of Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha Kashiwa, 277-8577 Chiba, Japan. ngotohda@east.ncc.go.jp
authors.forename: Naoto
authors.initials: N
authors.lastname: Gotohda
authors.forename: Hiromi
authors.initials: H
authors.lastname: Iwagaki
authors.forename: Michitaka
authors.initials: M
authors.lastname: Ozaki
authors.forename: Taira
authors.initials: T
authors.lastname: Kinoshita
authors.forename: Masaru
authors.initials: M
authors.lastname: Konishi
authors.forename: Toshio
authors.initials: T
authors.lastname: Nakagohri
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Takahashi
authors.forename: Shinya
authors.initials: S
authors.lastname: Saito
authors.forename: Takahito
authors.initials: T
authors.lastname: Yagi
authors.forename: Noriaki
authors.initials: N
authors.lastname: Tanaka
mesh_terms: D000368:Aged; D002277:Carcinoma / Q000097:blood / Q000601:surgery* / Q000821:virology; D015331:Cohort Studies; D005260:Female; D006498:Hepatectomy; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000150:complications / Q000601:surgery; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000150:complications / Q000601:surgery; D017228:Hepatocyte Growth Factor / Q000097:blood; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008113:Liver Neoplasms / Q000097:blood / Q000601:surgery* / Q000821:virology; D008115:Liver Regeneration / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D018121:Receptors, Cytokine / Q000097:blood; D048069:Tumor Necrosis Factors / Q000097:blood
chemical_list: C066855:HGF protein, human; D015850:Interleukin-6; D018121:Receptors, Cytokine; D048069:Tumor Necrosis Factors; D017228:Hepatocyte Growth Factor